Study pinpoints flaws in NCI's clinical trial system

04/12/2012 | Reuters

Cancer centers participating in the National Cancer Institute's Clinical Trials Cooperative Group program lose money after the beginning stages because all of it is spent early in the process, leaving none for follow-up, a study published in the Journal of Clinical Oncology found. Cancer centers must then start new clinical trials to fund follow-up in the older, ongoing trials. Instead, the NCI should use the model for industry-funded trials, disbursing funds as patients hit certain milestones during treatment and as they come back for follow-up visits, the researchers suggest.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN